Ensign Peak Advisors
MLAB icon

Ensign Peak Advisors’s Mesa Laboratories MLAB Stock Holding History

Ensign Peak Advisors’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,640
Closed -$231K – 2051
2022
Q3 		$231K Hold
1,640
– – ﹤0.01% 1817
2022
Q2 		$334K Hold
1,640
– – ﹤0.01% 1628
2022
Q1 		$418K Hold
1,640
– – ﹤0.01% 1628
2021
Q4 		$538K Sell
1,640
-1,960
-54% -$615K ﹤0.01% 1601
2021
Q3 		$1.09M Hold
3,600
– – ﹤0.01% 1399
2021
Q2 		$976K Buy
3,600
+500
+16% +$127K ﹤0.01% 1445
2021
Q1 		$755K Hold
3,100
– – ﹤0.01% 1507
2020
Q4 		$889K Hold
3,100
– – ﹤0.01% 1443
2020
Q3 		$790K Hold
3,100
– – ﹤0.01% 1410
2020
Q2 		$672K Hold
3,100
– – ﹤0.01% 1402
2020
Q1 		$701K Hold
3,100
– – ﹤0.01% 1293
2019
Q4 		$773K Buy
+3,100
New +$726K ﹤0.01% 1417

Other funds holding MLAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Ensign Peak Advisors's MLAB Position: Q4 2022 in Review

Ensign Peak Advisors sold out of Mesa Laboratories (MLAB) in Q4 2022, closing a stake of 1,640 shares — an estimated $231K sold.

Ensign Peak Advisors first reported a position in MLAB in Q4 2019 and held it in 12 quarters. The position peaked at $1.09M in Q3 2021. 160 funds tracked by Wall St. Rank hold MLAB as of Q4 2022.

  • Ensign Peak Advisors reported no remaining Mesa Laboratories position as of Q4 2022 after selling out during the quarter.
  • Ensign Peak Advisors sold 1,640 Mesa Laboratories shares in Q4 2022, an estimated $231K.
  • Ensign Peak Advisors first reported a position in Mesa Laboratories in Q4 2019 and held it in 12 quarters.
  • Ensign Peak Advisors's Mesa Laboratories position peaked at $1.09M in Q3 2021.
  • 160 funds tracked by Wall St. Rank held Mesa Laboratories as of Q4 2022.

Based on Ensign Peak Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.